Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07360457
Eligibility Criteria:
Inclusion Criteria:
* Adults aged above 50 years old with a previous diagnosis of T2DM according to ADA 2025, who have been on either SGLT2 inhibitors or GLP-1 analogs for at least one year.
Exclusion Criteria:
* individuals with Type 1 Diabetes Mellitus
* non-diabetic individuals
* those taking prandial insulin
* patients with arthritis without osteoarthritis,
* those taking other medications contraindicated with study medications,
* pregnant or breastfeeding females
* those allergic to active ingredients,
* those using corticosteroids, Autoimmune disease patients or patients receiving immunotherapies, monoclonal antibody targeting TNF-α or IL-6.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT07360457
Study Brief:
Protocol Section:
NCT07360457